Related Experiment Video
Updated: Dec 3, 2025

07:30
Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
Published on: November 21, 2012
14.1K
Voltage-Dependent Dopamine Potency at D1-Like Dopamine Receptors
Richard Ågren1, Kristoffer Sahlholm1,2,3
1Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Frontiers in Pharmacology
|October 29, 2020
Summary
Transmembrane voltage significantly alters dopamine
Area of Science:
- Neuroscience
- Molecular Pharmacology
- Cellular Electrophysiology
Background:
- Transmembrane voltage influences agonist potency at G protein-coupled receptors (GPCRs).
- Voltage sensitivity of dopamine D2-like receptors is known, but not for D1-like receptors.
- Dopamine D1-like receptors (D1R, D5R) primarily couple to Gαs/olf proteins.
Purpose of the Study:
- To investigate the impact of transmembrane voltage on dopamine potency at D1R and D5R.
- To determine how voltage affects dopamine dissociation rates (koff) at D1R and D5R.
- To elucidate the G protein coupling pathways involved in voltage-dependent dopamine signaling at D1R and D5R.
Main Methods:
- Assay of dopamine potency using GIRK channel activation in Xenopus oocytes co-expressing D1R or D5R at -80 mV and 0 mV.
- Measurement of GIRK response deactivation rates to estimate dopamine dissociation rate (koff) constants.
- Pertussis toxin (PTX) treatment and Gαs antisense oligonucleotide injection to probe G protein involvement.
Main Results:
- Depolarization from -80 mV to 0 mV reduced dopamine potency approximately 7-fold at both D1R and D5R.
- This reduction in potency correlated with increased estimated dopamine koff at both receptors.
- D1R responses were PTX-insensitive, while D5R responses showed significant reduction with PTX treatment and Gαs antisense.
Conclusions:
- Depolarization decreases dopamine affinity at both D1R and D5 receptors.
- Voltage-dependent dopamine affinities at D1R and D5R may play a role in learning and memory.
- D5R signaling involves both Gαs/olf and potentially Gαi/o pathways, influenced by voltage.
Keywords:
G protein selectivityG protein-coupled receptorGIRK channelsbinding kineticsdopamine D1 receptor (D1R)dopamine D5 receptor (D5R)voltage sensitivityMore Related Videos
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
1.9K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.9K
Dose-Response Relationship: Potency and Efficacy
6.0K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.0K
Dose-Response Relationship: Overview
4.5K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.5K
Antipsychotic Drugs: Typical and Atypical Agents
580
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
580
Cholinergic Receptors: Nicotinic
4.8K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
4.8K
Adrenergic Agonists: Indirect-Acting Agents
2.4K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.4K

